Medicine Platform
搜索
Product Catagories
首页 > Pharmaceutical Materials > Annexin A1 (1-25) (dephosphorylated)/Annexin-1 (2-26) (human)/Lipocortin-1 (2-26)/ Calpactin II (1-2
Annexin A1 (1-25) (dephosphorylated)/Annexin-1 (2-26) (human)/Lipocortin-1 (2-26)/ Calpactin II (1-2
单价 面议对比
询价 暂无
发货
过期 长期有效
更新 2025-08-14 03:30
 
详细信息

Grade: Research grade

Factory Location: Hangzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe, Australasia,Asia,Middle East,Africa

Monthly Production Capacity: hundreds of grams

Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag

Delivery Lead Time: In stock or 2-3 weeks

Sample Provided: yes

Payment Terms: T/T

The expression of Annexin A1 in different tumor tissues is different, even in the same tumor, the expression of different types is also different. The abnormal expression of Annexin A1 and changes in intracellular localization may be related to the differentiation and metastasis of various malignant tumors. Annexin A1 has a strong relationship with tumors and can be used as a new criterion for early diagnosis, treatment and postoperative tumors. In peptide synthesis, Annexin A1 (1-25) is composed of 25 amino acids coupled with an acetylated structure at the N-terminus.